BIOMAT Database Logo BIOMAT Database Logo

Longitudinally extensive transverse myelitis after covid vaccination: Response to letter. 2022

Seyed Farzad Maroufi, and Fereshteh Naderi Behdani, and Fatemeh Rezania, and Samaneh Tanhapour Khotbehsara, and Zahra Mirzaasgari
Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

UI MeSH Term Description Entries
D009188 Myelitis, Transverse Inflammation of a transverse portion of the spinal cord characterized by acute or subacute segmental demyelination or necrosis. The condition may occur sporadically, follow an infection or vaccination, or present as a paraneoplastic syndrome (see also ENCEPHALOMYELITIS, ACUTE DISSEMINATED). Clinical manifestations include motor weakness, sensory loss, and incontinence. (Adams et al., Principles of Neurology, 6th ed, pp1242-6) Demyelinative Myelitis,Transverse Myelitis,Myelitis, Acute Transverse,Myelitis, Necrotizing,Myelitis, Paraneoplastic,Myelitis, Postinfectious,Myelitis, Postvaccinal,Myelitis, Subacute Transverse,Postinfectious Myelitis,Transverse Myelopathy Syndrome,Acute Transverse Myelitis,Myelitides, Subacute Transverse,Myelitis, Demyelinative,Necrotizing Myelitis,Paraneoplastic Myelitis,Postvaccinal Myelitis,Subacute Transverse Myelitis,Transverse Myelitis, Acute,Transverse Myelitis, Subacute,Transverse Myelopathy Syndromes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086663 COVID-19 Vaccines Vaccines or candidate vaccines containing SARS-CoV-2 component antigens, genetic materials, or inactivated SARS-CoV-2 virus, and designed to prevent COVID-19. 2019 Novel Coronavirus Vaccine,2019 Novel Coronavirus Vaccines,2019-nCoV Vaccine,2019-nCoV Vaccines,COVID 19 Vaccine,COVID-19 Vaccine,COVID-19 Virus Vaccine,COVID-19 Virus Vaccines,COVID19 Vaccine,COVID19 Vaccines,COVID19 Virus Vaccine,COVID19 Virus Vaccines,Coronavirus Disease 2019 Vaccine,Coronavirus Disease 2019 Vaccines,Coronavirus Disease 2019 Virus Vaccine,Coronavirus Disease 2019 Virus Vaccines,Coronavirus Disease-19 Vaccine,Coronavirus Disease-19 Vaccines,SARS Coronavirus 2 Vaccines,SARS-CoV-2 Vaccine,SARS-CoV-2 Vaccines,SARS2 Vaccine,SARS2 Vaccines,2019 nCoV Vaccine,2019 nCoV Vaccines,COVID 19 Vaccines,COVID 19 Virus Vaccine,COVID 19 Virus Vaccines,Coronavirus Disease 19 Vaccine,Coronavirus Disease 19 Vaccines,SARS CoV 2 Vaccine,SARS CoV 2 Vaccines,Vaccine, 2019-nCoV,Vaccine, COVID 19,Vaccine, COVID-19,Vaccine, COVID-19 Virus,Vaccine, COVID19,Vaccine, COVID19 Virus,Vaccine, Coronavirus Disease-19,Vaccine, SARS-CoV-2,Vaccine, SARS2,Vaccines, 2019-nCoV,Vaccines, COVID-19,Vaccines, COVID-19 Virus,Vaccines, COVID19,Vaccines, COVID19 Virus,Vaccines, Coronavirus Disease-19,Vaccines, SARS-CoV-2,Vaccines, SARS2,Virus Vaccine, COVID-19,Virus Vaccine, COVID19,Virus Vaccines, COVID-19,Virus Vaccines, COVID19
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations

Related Publications

Seyed Farzad Maroufi, and Fereshteh Naderi Behdani, and Fatemeh Rezania, and Samaneh Tanhapour Khotbehsara, and Zahra Mirzaasgari
Longitudinally Extensive Transverse Myelitis.
January 2019, Indian journal of pediatrics,
Seyed Farzad Maroufi, and Fereshteh Naderi Behdani, and Fatemeh Rezania, and Samaneh Tanhapour Khotbehsara, and Zahra Mirzaasgari
Longitudinally extensive transverse myelitis.
June 2014, Current opinion in neurology,
Seyed Farzad Maroufi, and Fereshteh Naderi Behdani, and Fatemeh Rezania, and Samaneh Tanhapour Khotbehsara, and Zahra Mirzaasgari
A case of longitudinally extensive transverse myelitis following vaccination against Covid-19.
September 2021, Journal of neuroimmunology,
Seyed Farzad Maroufi, and Fereshteh Naderi Behdani, and Fatemeh Rezania, and Samaneh Tanhapour Khotbehsara, and Zahra Mirzaasgari
Hemorrhagic Longitudinally Extensive Transverse Myelitis.
January 2016, Case reports in neurological medicine,
Seyed Farzad Maroufi, and Fereshteh Naderi Behdani, and Fatemeh Rezania, and Samaneh Tanhapour Khotbehsara, and Zahra Mirzaasgari
Longitudinally extensive transverse myelitis after Campylobacter jejuni enteritis.
April 2018, Practical neurology,
Seyed Farzad Maroufi, and Fereshteh Naderi Behdani, and Fatemeh Rezania, and Samaneh Tanhapour Khotbehsara, and Zahra Mirzaasgari
Longitudinally extensive transverse myelitis following acute COVID-19 infection.
February 2021, Multiple sclerosis and related disorders,
Seyed Farzad Maroufi, and Fereshteh Naderi Behdani, and Fatemeh Rezania, and Samaneh Tanhapour Khotbehsara, and Zahra Mirzaasgari
Diagnosis of longitudinally extensive transverse myelitis.
February 2011, BMJ case reports,
Seyed Farzad Maroufi, and Fereshteh Naderi Behdani, and Fatemeh Rezania, and Samaneh Tanhapour Khotbehsara, and Zahra Mirzaasgari
Dengue-related Longitudinally Extensive Transverse Myelitis.
January 2019, Neurology India,
Seyed Farzad Maroufi, and Fereshteh Naderi Behdani, and Fatemeh Rezania, and Samaneh Tanhapour Khotbehsara, and Zahra Mirzaasgari
Dengue-associated longitudinally extensive transverse myelitis.
March 2024, BMJ case reports,
Seyed Farzad Maroufi, and Fereshteh Naderi Behdani, and Fatemeh Rezania, and Samaneh Tanhapour Khotbehsara, and Zahra Mirzaasgari
Refractory Longitudinally Extensive Transverse Myelitis Responsive to Cyclophosphamide.
November 2017, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
Copied contents to your clipboard!